| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 24587-37-9 | L-Tryptophan, L-valyl-; L-Tryptophan,N-L-valyl-; Tryptophan, N-L-valyl-, L- (8CI); 117: PN: WO2006024694 SEQID: 117claimed protein; L-Valyl-L-tryptophan; Valyltryptophan |  | C16H21N3O3 | 詳情 | 供應商 | |
| 41961-56-2 | L-Proline,L-threonyl-L-lysyl-; L-Proline,1-(N2-L-threonyl-L-lysyl)-; (Des-Arg4)-tuftsin; MIP; Macrophage inhibitorypeptide |  | C15H28N4O5 | 詳情 | 供應商 | |
| 34367-74-3 | L-Phenylalaninamide,L-arginylglycyl-L-phenylalanyl- (9CI); Alaninamide,L-arginylglycyl-L-phenylalanylphenyl-, L- (8CI); 1: PN: WO0172770 SEQID: 1claimed protein; Arginylglycylphenylalanylphenylalaninamide |  | C26H36N8O4 | 詳情 | 供應商 | |
| 130170-10-4 | L-Lysine,N2-[N-[N-[N-(1-oxododecyl)glycyl]-L-seryl]-L-seryl]- (9CI); myristoyl-glycyl-seryl-seryl-lysine |  | C26H49N5O8 | 詳情 | 供應商 | |
| 71074-48-1 | L-Aspartic acid,N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-a-glutamyl- (9CI); L-Asparticacid, N-[N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-a-glutamyl]-; GW 3347; NSC 292225 |  | C24H27N9O8 | 詳情 | 供應商 | |
| 75059-08-4 | L-Methioninamide,L-tyrosyl-D-alanyl-D-alanyl-L-phenylalanyl- (9CI); Tyr-D-Ala-D-Ala-Phe-Met-NH2 |  | C29H40N6O6S | 詳情 | 供應商 | |
| 23931-59-1 | L-Lysine,N6-(1-deoxy-D-fructos-1-yl)-N2-formyl- (9CI); D-Fructose,1-[[5-carboxy-5-(formylamino)pentyl]amino]-1-deoxy-, (S)-; Fructose,1-[(5-carboxy-L-5-formamidopentyl)amino]-1-deoxy-, D- (8CI); L-Lysine,D-fructose deriv.; Na-Formyl-Ne-(1-deoxy-D-fructos-1-yl)-L-lysine |  | C13H24N2O8 | 詳情 | 供應商 | |
| 29289-02-9 | L-Arabinopyranoside,2-(3,4-dihydroxyphenyl)-3,4-dihydro-3,5-dihydroxy-2H-1-benzopyran-7-yl; Polydin(8CI) |  | C20H22O10 | 詳情 | 供應商 | |
| 13443-57-7 | L-Ascorbic acid,3-O-methyl-; Ascorbicacid, 3-O-methyl- (7CI); 3-O-Methyl-L-ascorbic acid; 3-O-Methylascorbic acid; L-Ascorbic acid 3-methyl ether |  | C7H10O6 | 詳情 | 供應商 | |
| 153006-44-1 | L-Methionine,N-[(2R)-2-(mercaptomethyl)-3-(2-methylphenyl)-1-oxopropyl]-; L-Methionine,N-[2-(mercaptomethyl)-3-(2-methylphenyl)-1-oxopropyl]-, (R)-; CGS 26129 |  | C16H23NO3S2 | 詳情 | 供應商 | |
| 139026-55-4 | L-Isoleucinamide,L-tyrosyl-L-arginyl- (9CI); Antho-RIamideII |  | C21H35N7O4 | 詳情 | 供應商 | |
| 64821-31-4 | L-Homocysteine,S-[2-[1-(6-amino-9H-purin-9-yl)-2-oxoethoxy]-3-oxopropyl]-, [R-(R*,S*)]- (9CI) |  | C14H18N6O5S | 詳情 | 供應商 | |
| 65149-23-7 | L-Phenylalaninamide,L-prolyl-N-[(1S)-4-[(aminoiminomethyl)amino]-1-(2-chloroacetyl)butyl]-; L-Phenylalaninamide,L-prolyl-N-[(1S)-4-[(aminoiminomethyl)amino]-1-(chloroacetyl)butyl]- (9CI); L-Phenylalaninamide,L-prolyl-N-[4-[(aminoiminomethyl)amino]-1-(chloroacetyl)butyl]-, (S)-; 4: PN:US20070207960 PAGE: 27 claimed protein; L-Prolyl-L-phenylalanyl-L-argininechloromethyl ketone |  | C21H31ClN6O3 | 詳情 | 供應商 | |
| 145452-14-8 | L-Serine, O-(2-O-a-D-mannopyranosyl-a-D-mannopyranosyl)-; O-(2-O-mannopyranosyl-mannopyranosyl)serine |  | C15H27NO13 | 詳情 | 供應商 | |
| 137182-25-3 | L-Valinamide,L-phenylalanyl-D-asparaginyl-L-a-glutamyl-L-phenylalanyl- (9CI); Fulicin |  | C32H43N7O8 | 詳情 | 供應商 | |
| 116286-76-1 | L-Tryptophan,monolithium salt (9CI); (S)-Tryptophanlithium salt; Lithium L-tryptophanate |  | C11H11LiN2O2 | 詳情 | 供應商 | |
| 27832-86-6 | Lanosta-7,9(11)-dien-18-oicacid, 3,17,20-trihydroxy-25-methoxy-, g-lactone, (3b,20x)- (9CI); 20x-Lanosta-7,9(11)-dien-18-oicacid, 3b,17,20-trihydroxy-25-methoxy-, g-lactone (8CI); Praslinogenin |  | C31H48O5 | 詳情 | 供應商 | |
| 138749-62-9 | L-Leucine,N-[N-[N-[N-[N-(N-L-histidyl-L-tryptophyl)-L-alanyl]-L-valyl]-D-alanyl]-L-histidyl]-(9CI); gastrin releasing peptide (20-26), Ala(24)- |  | C40H56N12O8 | 詳情 | 供應商 | |
| 80063-35-0 | L-Phenylalaninamide,N-[(1,1-dimethylethoxy)carbonyl]glycyl-L-tyrosyl-L-methionyl-L-a-aspartyl- (9CI); rat gastrin C-terminal pentagastrin |  | C34H46N6O10S | 詳情 | 供應商 | |
| 110024-17-4 | Lanosta-8,24-dien-26-oicacid, 3,22-bis(acetyloxy)-7,15-dihydroxy-, (3a,7a,15a,24E)- (9CI); Ganodericacid Mh |  | C34H52O8 | 詳情 | 供應商 | |